INO
Inovio Pharmaceuticals Inc
1.20$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.3% | +60.8% | +12.4% | +44.0% | +10.4% | -16.1% | +2.2% | +16.2% | -36.3% | -10.7% | -4.5% | |
| – | +14.0% | +69.4% | +24.7% | -18.5% | +2.3% | +43.5% | +68.3% | -14.4% | -50.9% | -40.4% | -43.1% | |
| – | -9.9% | +69.6% | +64.1% | -33.9% | +69.7% | +450.2% | -71.4% | +9.3% | – | – | – | |
| – | +529.6% | -104.0% | – | +62.6% | -175.2% | – | – | -60.6% | -151.7% | – | – | |
| – | +101.6% | +41.6% | +161.4% | -79.7% | -52.6% | +53.9% | -19.0% | -21.3% | -66.9% | +52.0% | -41.4% | |
| – | +53.1% | – | -271.0% | – | -121.3% | +550.0% | +198.2% | – | -20.3% | +19.1% | -86.5% | |
| – | – | – | – | – | – | -95.9% | – | – | – | – | – | |
| – | +42.7% | +5,088,580.3% | -100.0% | -100.6% | +46.0% | +351.1% | +14.5% | -69.7% | – | – | – | |
| – | – | – | +0.0% | +0.0% | -3.4% | -99.8% | -100.0% | – | – | – | -100.0% | |
| – | +16.4% | -90.8% | +1,128.9% | -67.6% | +239.6% | +341.5% | -54.5% | -61.3% | -93.9% | +930.5% | +3.1% | |
| – | +150.4% | -325.3% | – | -102.0% | – | – | -178.6% | – | – | – | -141.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.